For instance, in glioblastoma and sporadic colorectal cancer, MGMT and MLH1 promoter methylation analyses through methylation‐sensitive pyrosequencing are employed for diagnostic and prognostic purposes.283, 284. Here, MLH1 is linked to glioblastoma.